-
-
-
-
-
-
-
Organon (OGN) Misses Q1 EPS by 12c
-
-
-
-
-
-
-
Organon's VTAMA cream gets strong recommendation in pediatric dermatitis guidelines
-
-
-
-
-
-
-
Increasing unusual call option volume: BNC AIG OGN USAS GFS MOD REPL WSM IVZ
-
-
-
-
-
-
-
European Commission approves Henlius and Organon denosumab biosimilars
-
-
-
-
-
-
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
-
-
-
-
-
-
OGN DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN
-
-
-
-
-
-
-
OGN FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OG
-
446,445 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

